Life Science Intelligence Blog

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

IsoPlexis completes Series D round, raising $85M

IsoPlexis develops an end-to-end solution proteomics platform for curative medicine development. The IsoSpark platform is capable of evaluating the safety and efficacy of new therapeutics for chronic diseases and cancers. To-date, the company has raised approximately $154M in funding. Illumina, Qiagen, and Thermo Fisher are some of the key strategics in the molecular diagnostics market.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Pear Therapeutics raises $80M in Series D round

Pear Therapeutics develops prescription digital therapeutics for the treatment of opioid use and substance use disorder. The company recently received FDA clearance for a third digital therapeutic for the treatment of chronic insomnia. According to a press release from the company, funds from the round will be invested in the commercialization of these three digital therapeutics, including the acceleration of reimbursement coverage.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

EverlyWell – delivering lab-quality diagnostic testing directly to patients’ homes

EverlyWell is simplifying the process for receiving diagnostic testing by allowing patients to collect and send-off testing samples from home. Results are digitally delivered to patients within a few days. The company offers diagnostic tests for general wellness, men’s and women’s health, metabolic health, sexual health, and COVID-19. EverlyWell recently closed a Series D round worth $175M, bringing the total funds raised to-date by the company to $250M. Key strategics in the diagnostic testing market include Abbott, Illumina, and Roche.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

GT Medical Technologies closes Series B funding round

The round, funded by MVM Life Science Partners and two other investors, raised $16M to support the commercialization of the company’s FDA-cleared GammaTile Therapy. GT Medical’s GammaTile therapy is placed directly at the location of a brain tumor’s post-surgical excision to irradiate residual tumor cells and prevent tumor cell replication and recurrence. With the completion of this recent fundraising round, the company has raised approximately $29M. Accuray, Elekta, and Varian are some of the key strategics in the market for targeted radiation therapy.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Subtle Medical raises $12.2M in Series A round

Subtle Medical develop solutions to improve medical imaging using artificial intelligence. The company’s proprietary algorithms are currently being applied to the FDA-cleared SubtlePET for AI-analysis of PET images and SubtleMR platform for the analysis MRI images. Competitors in the AI medical image analysis market include Arterys, Behold.ai, and Zebra Medical Vision.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Neuros Medical is raising $42.8M in equity

Currently the company has completed the sale of $37M in equity from 24 investors. Neuros Medical is a developer of proprietary neuromodulation technology for the treatment of chronic pain. Neuros’ Altius System uses an implantable generator to deliver electrical signals in the peripheral nervous system to block pain signals. Major competitors in the neuromodulation market include Abbott, Boston Scientific, and LivaNova.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Venari Medical completes $5.3M Seed round

The company is developing BioVena, a catheter-based therapy for chronic venous disease. BioVena disrupts the inner vessel lining, which causes natural scarring and vessel closure that diverts blood away from the diseased vessels. Abbott, Boston Scientific, and Edwards are some of the key strategics in the competitive landscape.

Start a Free Trial to Medtech Startup Tracker Today

LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Diality – bringing dialysis into the patient’s home

Diality is developing a portable home hemodialysis machine intended to help improve the quality of life of patient’s with kidney disease. The company’s product is currently pending CE Mark in the EU and FDA clearance in the US. Diality has raised $30.5M in capital as of October 2020. Key strategics in the hemodialysis market include Baxter, Fresenius, and Nipro.

Start a Free Trial to Medtech Startup Tracker Today

In the latest report available in LSI's Medtech Pro Platform, Impact of 2020 Crisis on Global Medical Devices & Diagnostics Market, new forecasts and analysis based on the impact of COVID-19 are provided. More specifically, the report details the impact of the crisis annually for 2020 through 2025 on:

The presence of an arrhythmia is confirmed when the heart beats at an irregular rate. Persistent arrhythmia necessitates clinical evaluation and may require some form of intervention to prevent the irregularity from becoming life-threatening. When left untreated, serious forms of arrhythmia can lead to serious complications, such as stroke and heart failure. Recurring arrhythmia can be managed with a number of therapeutic options, including pharmaceuticals, implantable devices (e.g. pacemakers), and ablative procedures.